CSLF6 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CSLF6 antibody; Os08g0160500 antibody; LOC_Os08g06380 antibody; OsJ_025078 antibody; P0577B11.104-1 antibody; P0672D01.120-1Probable mixed-linked glucan synthase 6 antibody; EC 2.4.1.- antibody; 1,3;1,4-beta-D-glucan synthase 6 antibody; Cellulose synthase-like protein F6 antibody; OsCslF6 antibody
Target Names
CSLF6
Uniprot No.

Target Background

Function
CSLF6 Antibody catalyzes both beta-1,3 and beta-1,4 glycosidic linkages on beta-D-glucan. This enzyme is essential for the synthesis of (1,3;1,4)-beta-D-glucans in grasses and cereals (Poaceae). These mixed-linked glucans, which are not found in the walls of dicotyledons or most other monocotyledonous plants, are particularly important components of the walls of the starchy endosperm and aleurone cells of cereal grains such as oats, wheat, rice, and barley. They can comprise up to 70% of the wall by weight.
Database Links
Protein Families
Glycosyltransferase 2 family, Plant cellulose synthase-like F subfamily
Subcellular Location
Golgi apparatus membrane; Multi-pass membrane protein.

Q&A

What is the CSLF6 enzyme and why are antibodies against it important in plant research?

CSLF6 is an integral membrane protein and a major component of the (1,3;1,4)-β-glucan synthase complex in cereals. This enzyme plays a crucial role in synthesizing mixed linkage glucan (MLG), an important component of cereal cell walls. Antibodies against CSLF6 are essential research tools that enable visualization of protein localization, quantification of expression levels, and validation of mutant lines.

The CSLF6 protein adopts a CesA-like fold with transmembrane helices and a cytosolic glycosyltransferase (GT) domain. Research has shown that CSLF6 has two specific insertions - the plant-conserved region (PCR) corresponding to residues 245-390 and the class-specific region (CSR) . Antibodies targeting these specific domains can provide insights into protein structure-function relationships.

How do I select the appropriate epitope for generating CSLF6 antibodies?

When designing CSLF6 antibodies, epitope selection is critical. Effective CSLF6 antibodies have been generated against:

  • Multi-epitope antigens containing 7-10 amino acid segments from different protein regions

  • Conserved peptide sequences spanning key functional domains

  • N-terminal extracellular domains for cell surface detection without permeabilization

  • C-terminal cytoplasmic domains for intracellular detection following permeabilization

For example, Wilson et al. (2015) successfully utilized a polyclonal antibody generated against the peptide AKGKHGFLPLPKKTYGK (1:2,000 dilution) and a monoclonal antibody (1:500) derived from a hybridoma line (7G3A6) against the same peptide . This epitope corresponds to a segment of the CSLF6 protein that contains conserved residues important for enzymatic function.

Consider targeting unique regions that distinguish CSLF6 from other CSL proteins to minimize cross-reactivity, particularly when studying multiple CSL gene family members simultaneously.

What controls should be included when using CSLF6 antibodies in flow cytometry experiments?

When designing flow cytometry experiments using CSLF6 antibodies, proper controls are essential to ensure specificity and accurate data interpretation:

  • Unstained cells - To establish baseline autofluorescence levels, particularly important in plant cells which may have high natural fluorescence

  • Negative controls - Cells known not to express CSLF6 (e.g., knockout mutants like cslf6-2) to validate antibody specificity

  • Isotype controls - Antibodies of the same class as the CSLF6 antibody but with no specificity for the target, to assess Fc receptor binding

  • Secondary antibody controls - Cells treated only with labeled secondary antibody to detect non-specific binding

  • Blocking controls - Samples pre-incubated with unlabeled primary antibody to confirm signal specificity

Additionally, when working with plant cells expressing CSLF6, maintain samples on ice with 0.1% sodium azide to prevent internalization of membrane-localized CSLF6 protein. Cell viability should exceed 90% to minimize false positives from dead cell staining .

How should I optimize protein extraction protocols for CSLF6 detection in immunoblotting?

For optimal CSLF6 detection in immunoblotting:

Microsomal Membrane Preparation Protocol:

  • Homogenize plant tissue in buffer containing 50 mM HEPES (pH 7.5), 250 mM sucrose, 3 mM DTT, and protease inhibitors

  • Centrifuge at 10,000× g for 10 minutes at 4°C to remove debris

  • Collect supernatant and ultracentrifuge at 100,000× g for 60 minutes at 4°C

  • Resuspend microsomal membrane pellet in homogenization buffer without DTT

  • Solubilize proteins in sample buffer (0.125 M Tris-HCl pH 6.8, 15% glycerol, 3% SDS, 0.2 M DTT) at 40°C for 1 hour (avoid boiling, which can cause aggregation of membrane proteins)

For immunoblotting detection, use a 1:1000-1:2000 dilution of CSLF6 antibody with chemiluminescence detection. This method has been successfully used for detecting both native and epitope-tagged CSLF6 proteins .

CSLF6 typically appears as a band of approximately 105 kDa on Western blots, while truncated variants (e.g., W614* mutant) may appear at lower molecular weights (approximately 67.5 kDa) .

How can immunohistochemical techniques with CSLF6 antibodies be optimized for studying (1,3;1,4)-β-glucan distribution in plant tissues?

Optimizing immunohistochemical detection of CSLF6 and (1,3;1,4)-β-glucan requires specific techniques:

Protocol for (1,3;1,4)-β-glucan Distribution Analysis:

  • Harvest tissues at developmentally relevant stages (e.g., 15 DPA for HvCslF9 expression peak in grain)

  • Fix tissues in 4% paraformaldehyde in PBS

  • Prepare thin sections (5-10 μm) and mount on slides

  • Block with 3-5% BSA in PBS to reduce non-specific binding

  • Incubate with primary antibody (BG1 antibody for (1,3;1,4)-β-glucan detection)

  • Apply fluorescently-labeled secondary antibody

  • Counterstain with calcofluor to visualize cell walls or iodine to detect starch granules

  • Image using confocal microscopy with appropriate filters

This approach enables visualization of (1,3;1,4)-β-glucan in specific cell types and developmental stages. In wildtype barley grain, (1,3;1,4)-β-glucan is detected in the starchy endosperm and aleurone cell walls, while in cslf6-2 homozygous mutants, labeling is completely absent in the endosperm with only weak fluorescence in sub-aleurone cells .

For co-localization studies, combine CSLF6 antibody labeling with BG1 antibody to correlate enzyme presence with product accumulation.

What approaches can be used to validate CSLF6 antibody specificity in CRISPR/Cas9-generated mutant lines?

Validating CSLF6 antibody specificity in CRISPR/Cas9 mutant lines involves multiple complementary approaches:

Validation Strategy for CSLF6 Antibodies in Mutant Lines:

  • Immunoblot comparison:

    • Compare protein extracts from wildtype and cslf6 knockout mutants

    • Expect absence of specific band in complete knockout lines

    • For point mutations, confirm altered protein size in frameshift mutants

  • Quantitative correlation:

    • Measure (1,3;1,4)-β-glucan content using enzymatic assays

    • Compare with CSLF6 protein levels by immunoblotting

    • Heterozygous cslf6-2/+ lines show intermediate levels of both CSLF6 protein and (1,3;1,4)-β-glucan (1.45% w/w ± 0.31) compared to wildtype (5.00% w/w ± 0.03)

  • Immunohistochemical validation:

    • Perform immunolabeling of tissue sections from wildtype and mutant plants

    • Compare labeling patterns with known (1,3;1,4)-β-glucan distribution

    • Confirm altered/absent labeling in mutant tissues matches biochemical data

  • Genetic complementation:

    • Express tagged CSLF6 in knockout background

    • Verify antibody detection of the tagged protein

    • Confirm restoration of (1,3;1,4)-β-glucan production

This multi-faceted approach ensures antibody specificity and provides correlative data between CSLF6 protein levels and (1,3;1,4)-β-glucan content.

How can CSLF6 antibodies be used to characterize functional variants in heterologous expression systems?

CSLF6 antibodies are valuable tools for characterizing functional variants through heterologous expression:

Heterologous Expression and Characterization Protocol:

  • Expression system preparation:

    • Transform Nicotiana benthamiana leaves with native BdCslF6 or mutant constructs

    • Include appropriate controls (non-infiltrated control, empty vector)

    • Harvest plant material 2 days post-infiltration (DPI)

  • Protein expression analysis:

    • Prepare microsomal membranes (40 μg total protein)

    • Perform immunoblotting with CSLF6 antibody (1:1000 dilution)

    • Compare expression levels across variants

    • Identify truncated products (e.g., W614* mutant produces a 67.5 kDa truncated protein compared to the full-length 105 kDa protein)

  • Activity correlation:

    • Prepare alcohol insoluble residues (AIR) from transformed tissues

    • Measure MLG content using enzymatic-HPAEC-PAD analysis

    • Calculate DP3:DP4 ratios to assess MLG structure changes

    • Normalize MLG content to CSLF6 protein expression levels

  • Structure-function analysis:

    • Compare amino acid substitutions with protein detection and activity

    • Map mutations to protein domains using immunodetection of truncated variants

    • Correlate structural predictions with functional outcomes

This approach has successfully identified functional domains and specific amino acids critical for CSLF6 activity, such as the A656T variant that affects MLG structure without eliminating enzymatic activity .

What methods can be used to study CSLF6 membrane topology using epitope-specific antibodies?

Studying CSLF6 membrane topology requires specialized antibody-based approaches:

Membrane Topology Analysis Methods:

  • Differential epitope accessibility:

    • Generate antibodies against predicted extracellular, transmembrane, and cytoplasmic domains

    • Compare antibody binding in intact vs. permeabilized cells

    • Epitopes accessible only after permeabilization are likely cytoplasmic

  • Protease protection assays:

    • Treat intact microsomes with proteases

    • Analyze protected fragments by immunoblotting with domain-specific antibodies

    • Cytoplasmic domains are protected in right-side-out vesicles

  • Glycosylation mapping:

    • Introduce glycosylation sites at various positions

    • Detect shifts in protein mobility by immunoblotting

    • Glycosylated sites indicate luminal/extracellular orientation

  • Epitope tagging:

    • Create constructs with tags at N-terminus, C-terminus, or internal loops

    • Compare detection with and without permeabilization

    • Combine with CSLF6-specific antibodies to validate native conformations

These approaches have revealed that CSLF6 adopts a conformation with multiple transmembrane helices, with the catalytic domain located on the cytoplasmic side where UDP-glucose substrate is available .

How can I resolve non-specific binding issues when using CSLF6 antibodies in plant tissues?

Non-specific binding is a common challenge when using CSLF6 antibodies in plant tissues. Here are methodological solutions:

Troubleshooting Non-Specific Binding:

  • Optimize blocking conditions:

    • Use 5-10% normal serum from the same host species as the secondary antibody

    • Add 0.1-0.5% non-ionic detergents (Triton X-100, Tween-20) to reduce hydrophobic interactions

    • Include 1-5% BSA to block protein-binding sites

  • Address plant-specific challenges:

    • Pre-absorb antibodies with wildtype plant extracts from cslf6 knockout tissues

    • Add 0.1-1% plant-derived proteins (e.g., non-fat milk) to blocking solutions

    • Consider the high phenolic and polysaccharide content in plant tissues

  • Validate signal specificity:

    • Compare wildtype and cslf6 knockout tissues

    • Include peptide competition controls (pre-incubate antibody with immunizing peptide)

    • Use multiple antibodies targeting different CSLF6 epitopes

  • Reduce autofluorescence for immunofluorescence:

    • Treat sections with 0.1% sodium borohydride to reduce aldehyde-induced fluorescence

    • Use Sudan Black B (0.1-0.3%) to quench lipofuscin autofluorescence

    • Include unstained controls to establish autofluorescence baseline

When using CSLF6 antibodies in barley grain sections, weak fluorescence observed in some tissues of cslf6-2 mutants may be partially due to autofluorescence from phenolic acids rather than specific antibody binding .

What approaches can address epitope masking or inaccessibility issues with CSLF6 antibodies?

CSLF6 is a complex membrane protein with multiple domains that may be inaccessible due to protein folding, membrane embedding, or interactions with other proteins:

Protocol for Addressing Epitope Masking:

  • Optimize fixation conditions:

    • Test different fixatives (paraformaldehyde, glutaraldehyde, methanol)

    • Vary fixation times and temperatures

    • Consider gentler cross-linking for membrane proteins

  • Enhance antigen retrieval:

    • Apply heat-induced epitope retrieval (citrate buffer pH 6.0, 95°C, 20 minutes)

    • Test enzymatic retrieval with proteases (proteinase K, trypsin)

    • Use detergent-based unmasking (0.5% SDS, 5 minutes)

  • Modify membrane permeabilization:

    • Increase permeabilization with higher detergent concentrations

    • Extend permeabilization time for better antibody penetration

    • Test different detergents (Triton X-100, saponin, digitonin)

  • Sample preparation adjustments:

    • For immunoblotting, avoid boiling samples (use 40°C for 1 hour instead)

    • Test native vs. denaturing conditions

    • Consider using multiple antibodies targeting different epitopes

  • Apply protein deglycosylation:

    • Treat samples with PNGase F to remove N-linked glycans

    • Test O-glycosidase for O-linked glycan removal

    • Evaluate whether glycosylation affects antibody accessibility

These approaches have successfully improved CSLF6 detection in various plant tissues and experimental systems .

How can CSLF6 antibodies be used to investigate protein-protein interactions in the (1,3;1,4)-β-glucan synthase complex?

CSLF6 antibodies are powerful tools for investigating protein-protein interactions within the (1,3;1,4)-β-glucan synthase complex:

Methodological Approaches for Protein Interaction Studies:

  • Co-immunoprecipitation (Co-IP):

    • Solubilize microsomal membranes with mild detergents (0.5-1% digitonin or n-dodecyl-β-D-maltoside)

    • Immunoprecipitate with CSLF6 antibody

    • Identify interacting partners by mass spectrometry

    • Validate interactions with reciprocal Co-IP

  • Proximity labeling:

    • Create CSLF6 fusion with BioID or TurboID proximity labeling enzymes

    • Express in plant systems and activate with biotin

    • Purify biotinylated proteins and identify by mass spectrometry

    • Validate potential interactors with CSLF6 antibodies

  • FRET/FLIM analysis:

    • Create fluorescent protein fusions with CSLF6 and potential partners

    • Perform Förster Resonance Energy Transfer (FRET) analysis

    • Use CSLF6 antibodies to validate proper localization and expression

  • Bimolecular Fluorescence Complementation (BiFC):

    • Split fluorescent protein fused to CSLF6 and candidate interactors

    • Observe fluorescence reconstitution when proteins interact

    • Confirm with immunolabeling using CSLF6 antibodies

This approach can investigate potential interactions between CSLF6 and other CSL family members, as research suggests there may be contributions from multiple enzymes. The cslf6-2 knockout lines provide an important "null" background for these experiments to investigate other components that might be involved in (1,3;1,4)-β-glucan synthesis .

What methods can be employed to study the dynamics of CSLF6 protein trafficking and membrane localization?

Understanding CSLF6 trafficking and localization is critical for elucidating (1,3;1,4)-β-glucan synthesis regulation:

Methods for CSLF6 Trafficking and Localization Studies:

  • Time-course immunolocalization:

    • Perform pulse-chase experiments with protein synthesis inhibitors

    • Fix cells at different time points

    • Use CSLF6 antibodies with organelle markers

    • Quantify colocalization changes over time

  • Subcellular fractionation and immunoblotting:

    • Separate cellular compartments (ER, Golgi, plasma membrane)

    • Prepare membrane fractions by differential centrifugation

    • Detect CSLF6 distribution using immunoblotting

    • Compare wildtype and mutant proteins

  • Live-cell imaging with tagged CSLF6:

    • Create fluorescent protein fusions

    • Perform FRAP (Fluorescence Recovery After Photobleaching)

    • Validate with immunofluorescence using CSLF6 antibodies

    • Compare dynamics in different cell types or developmental stages

  • Super-resolution microscopy:

    • Use techniques like STORM or PALM

    • Employ directly-labeled CSLF6 antibodies

    • Achieve nanometer-scale resolution of CSLF6 organization

    • Correlate with (1,3;1,4)-β-glucan deposition patterns

These approaches can reveal how CSLF6 trafficking relates to (1,3;1,4)-β-glucan deposition patterns in different cell types and developmental stages, as observed in immunolabeling studies of barley grain .

How can CSLF6 antibodies be used to investigate the impact of specific mutations on protein structure and function?

CSLF6 antibodies provide valuable tools for investigating structure-function relationships:

Structure-Function Analysis Methods:

  • Epitope mapping of functional domains:

    • Generate antibodies against specific domains

    • Compare antibody reactivity in wildtype and mutant proteins

    • Correlate with functional assays of enzyme activity

  • Conformational antibodies for structural analysis:

    • Develop antibodies that recognize specific conformational states

    • Use to probe structural changes in mutant variants

    • Compare results with activity measurements

  • Immunoprecipitation of mutant variants:

    • Isolate wildtype and mutant CSLF6 proteins

    • Analyze post-translational modifications

    • Identify differential interacting partners

  • Comparative analysis of multiple mutants:

    • Create a panel of CSLF6 variants with mutations in key domains

    • Analyze protein expression, localization, and stability by immunoblotting

    • Correlate with (1,3;1,4)-β-glucan content and structure

This approach has revealed that single amino acid changes in the transmembrane pore domain of CSLF6 can dramatically alter (1,3;1,4)-β-glucan structure without affecting protein expression levels. For example, changing Ile757 of barley CSLF6 to leucine alters the DP3:DP4 ratio to resemble that of maize, while the reciprocal change in maize CSLF6 (L757I) increases the DP3:DP4 ratio to match that of barley .

Table 1: Examples of successful CSLF6 antibody applications in research

ApplicationAntibody TypeEpitope/RegionDilutionKey FindingReference
ImmunoblottingPolyclonalAKGKHGFLPLPKKTYGK1:2,000Detection of full-length (105 kDa) and truncated CSLF6 variantsWilson et al., 2015
ImmunoblottingMonoclonal (7G3A6)AKGKHGFLPLPKKTYGK1:500Quantification of CSLF6 protein in heterologous expression systemsWilson et al., 2015
ImmunohistochemistryBG1 antibody ((1,3;1,4)-β-glucan)N/AN/AVisualization of (1,3;1,4)-β-glucan distribution in grain tissuesBurton et al., 2011
Western blottingT7 epitope tag antibodyN-terminal tag1:10,000Detection of heterologously expressed CSLF6 variantsJobling, 2015
Western blottingHvCslF6 antibodyMulti-epitope antigen1:1,000Analysis of CSLF6 in microsomal membrane preparationsJobling, 2015

Table 2: Comparison of CSLF6 knockout effects across different cereal species

SpeciesMutation TypeMLG ReductionPhenotypic EffectsReference
Barley (cslf6-2)CRISPR/Cas9 knockout97.8% reduction in grain (0.11% w/w vs. 5.00% w/w)Decreased TGW, flatter and longer grains, low germinationBurton et al., 2020
Barley (bgl mutants)Induced SNPsUndetectable levels (vs. 3.2% w/w in wildtype)30% reduction in height, some leaf chlorosis, slight yield decreaseTaketa et al., 2012
RiceT-DNA knockout97% reduction in coleoptiles, undetectable in other tissues33% reduction in height, otherwise normal developmentVega-Sánchez et al., 2012
WheatRNAi knockdown (endosperm-specific)30-53% reduction in whole grain flourMinimal effects on plant developmentNemeth et al., 2010
Brachypodium (A656T variant)TILLING mutantReduced MLG with altered DP3:DP4 ratioAltered carbon metabolism in grainBain et al., 2020

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.